GRI Bio announces 1-for-17 reverse stock split effective Feb 21, 2025

GRI Bio, Inc.

Reverse split at 1:17 ratio, effective 4:01 p.m. ET on Feb 21, 2025; post-split trading begins Feb 24, 2025 on Nasdaq under symbol GRI.
Outstanding shares will decrease from ~8.93 million to ~525,492; authorized share count unchanged.
Reverse split is intended to regain compliance with Nasdaq minimum bid price requirement.
Proportional adjustments will be made to exercise prices and shares for stock options, warrants, and convertible securities.
No fractional shares issued; cash payment in lieu based on closing price on Feb 21, 2025.

item 3.03 item 5.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

GRI Bio, Inc.: Filed Certificate of Amendment to effect a 1-for-17 reverse stock split (effective 2025-02-21).

Change: charter amendment
Effective: 2025-02-21

Exact text from the filing

On February 19, 2025, GRI Bio, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware an amendment (the “Certificate of Amendment”) to its amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company's common stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-17 (the “Reverse Stock Split”).

View on SEC.gov

Browse all governance changes →

GRI Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001824293-25-000042

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.